• 1
    Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000; 31: 330335.
  • 2
    Sasaki Y, Imaoka S, Kasugai H, et al. A new approach to chemoembolisation therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer. 1987; 60: 11941203.
  • 3
    Kasugai H, Kojima J, Tatsuta M, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology. 1989; 97: 965971.
  • 4
    Venook AP, Stagg RJ, Lewis BJ, et al. Chemoembolisation for hepatocellular carcinoma. J Clin Oncol. 1990; 8: 11081114.
  • 5
    Bruix J, Castells A, Montanya X, et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. Hepatology. 1994; 20: 643650.
  • 6
    Group d'Etude et de treatment du carcinoma hepatocellulaire. A comparison of lipiodol chemoembolisation and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995; 332: 12561261.
  • 7
    Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK, Tso WK. Transcather arterial chemoembolisation in inoperable hepatocellular carcinoma: four-year followup. J Vascu Interv Radiol. 1996; 7: 419425.
  • 8
    Liaw YF, Lin DY. Transcatheter hepatic arterial embolization in the treatment of hepatocellular carcinoma. Hepatogastroenterology. 1990; 37: 484488.
  • 9
    Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56: 918928.
  • 10
    Takayasu K, Suzuki M, Uesaka K, et al. Hepatic artery embolization for inoperable hepatocellular carcinoma, prognosis and risk factors. Cancer Chemother Pharmacol. 1989; 23: S123S125.
  • 11
    Vetter D, Wenger JJ, Bergier JM, Doffoel M, Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology. 1991; 13: 427433.
  • 12
    Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—a randomized controlled trial. Gastroenterology. 1988; 94: 453456.
  • 13
    Sato Y, Fujiwara K, Ogata I, et al. Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer. 1985;55: 28222825.
  • 14
    Patt YZ, Chuang VP, Wallace S, Benjamin RS, Fuqua R, Mavligit GM. Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. Cancer. 1983; 51: 13591363.
  • 15
    Miyoshi S, Minami Y, Kawata S, et al. Changes in hepatic functional reserve after transcatheter embolization of hepatocellular carcinoma. Assessment by maximal removal rate of indocyanine green. J Hepatol. 1988;6: 332336.
  • 16
    Khan KN, Nakata K, Kusumoto Y, et al. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma. Cancer Res. 1991; 51: 56675671.
  • 17
    Chen C, Tsang YM, Hsueh PR, et al. Bacterial infections associated with hepatic arteriography and transarterial embolization for hepatocellular carcinoma: a prospective study. Clin Infect Dis. 1999; 29: 161166.
  • 18
    Chen C, Chen PJ, Yang PM, et al. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997; 92: 22572259.
  • 19
    Takayasu K, Moriyama N, Muramatsu Y, et al. Gallbladder infarction after hepatic artery embolisation. AJR Am J Roentgenol. 1985; 144: 135138.
  • 20
    Sata T, Higashi Y, Ono Y. Sonography of gallbladder perforation: a complication of transcatheter hepatic arterial embolisation. J Ultrasound Med. 1986; 5: 715718.
  • 21
    Nakamura H, Kondoh H. Emphysematous cholecystitis: complications of hepatic arterial embolisation. Cariovasc Intervent Radiol. 1986; 9: 152153.